Elevance Health
(NYSE) ELV
Elevance Health Financials at a Glance
Market Cap
$63.21B
Revenue (TTM)
$199.13B
Net Income (TTM)
$5.66B
EPS (TTM)
$25.11
P/E Ratio
11.41
Dividend
$6.85
Beta (Volatility)
0.45 (Low)
Dividend
$6.85
Beta (Volatility)
0.45 (Low)
Price
$286.15
Volume
1,353,208
Open
$291.19
Price
$286.15
Volume
1,353,208
Open
$291.19
Previous Close
$286.39
Daily Range
$282.46 - $293.87
52-Week Range
$273.71 - $458.75
Dividend
$6.85
Beta (Volatility)
0.45 (Low)
Price
$286.15
Volume
1,353,208
Open
$291.19
Previous Close
$286.39
Daily Range
$282.46 - $293.87
52-Week Range
$273.71 - $458.75
ELV News
What Is the Fortune 100?
ELV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Elevance Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
97,100
CEO
Gail Koziara Boudreaux, MBA
Website
www.elevancehealth.comHeadquarters
Indianapolis, IN 46204, US
ELV Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
4%
Net Income Margin
3%
Return on Equity
13%
Return on Capital
8%
Return on Assets
5%
Earnings Yield
8.76%
Dividend Yield
0.02%
Payout Ratio
27.00%
Stock Overview
Market Cap
$63.21B
Shares Outstanding
220.71M
Volume
1.35M
Short Interest
0.00%
Avg. Volume
1.88M
Financials (TTM)
Gross Profit
$50.90B
Operating Income
$8.11B
EBITDA
$9.66B
Operating Cash Flow
$4.29B
Capital Expenditure
$1.12B
Free Cash Flow
$3.17B
Cash & ST Invst.
$9.49B
Total Debt
$33.23B
Elevance Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$49.75B
+9.5%
Gross Profit
$11.68B
-2.2%
Gross Margin
23.48%
N/A
Market Cap
$63.21B
N/A
Market Cap/Employee
$606.60K
N/A
Employees
104,200
N/A
Net Income
$547.00M
+30.9%
EBITDA
$987.00M
-26.6%
Quarterly Fundamentals
Net Cash
$23.74B
+2.7%
Accounts Receivable
$15.23B
+16.7%
Inventory
$0.00
N/A
Long Term Debt
$31.86B
+4.3%
Short Term Debt
$1.38B
-36.3%
Return on Assets
4.66%
N/A
Return on Invested Capital
7.99%
N/A
Free Cash Flow
$209.00M
-154.4%
Operating Cash Flow
$84.00M
-88.1%